Immediate Impact
1 by Nobel laureates 13 from Science/Nature 57 standout
Citing Papers
Chemically Modified Platforms for Better RNA Therapeutics
2024 Standout
Overall survival with sacituzumab govitecan in hormone receptor-positive and human epidermal growth factor receptor 2-negative metastatic breast cancer (TROPiCS-02): a randomised, open-label, multicentre, phase 3 trial
2023 Standout
Works of Neil A. O’Brien being referenced
Neutralization of BCL-2/XL Enhances the Cytotoxicity of T-DM1 In Vivo
2019
Neratinib overcomes trastuzumab resistance in HER2 amplified breast cancer
2013
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Neil A. O’Brien | 1014 | 801 | 443 | 53 | 1.6k | |
| José Jiménez | 968 | 881 | 281 | 39 | 1.6k | |
| Brent N. Rexer | 896 | 998 | 398 | 36 | 1.7k | |
| Ron Yu | 932 | 717 | 335 | 31 | 1.7k | |
| Edward Rosfjord | 1005 | 922 | 375 | 39 | 1.8k | |
| Wolfgang Eicheler | 592 | 682 | 529 | 47 | 1.7k | |
| Ariella B. Hanker | 731 | 917 | 429 | 41 | 1.6k | |
| Cataldo Bianco | 761 | 752 | 421 | 35 | 1.4k | |
| Marta Guix | 1253 | 1090 | 619 | 42 | 2.2k | |
| Garry Schwartz | 1046 | 750 | 716 | 40 | 2.0k | |
| Maria Sundvall | 933 | 1160 | 299 | 32 | 1.8k |
All Works
Login with ORCID to disown or claim papers
Loading papers...